You are here

Article info

Article menu
Download PDFPDF
Inflammatory bowel disease
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

Authors

  1. ProfessorDr P Rutgeerts, Internal Medicine, Department of Gastroenterology, Herestraat 49, B-3000 Leuven, Belgium; Paul.Rutgeerts{at}uz.kuleuven.ac.be
View Full Text

Citation

Fidder H, Schnitzler F, Ferrante M, et al
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
Gut 2009;58:501-508.

Publication history

  • Revised August 22, 2008
  • Accepted September 2, 2008
  • First published October 2, 2008.
Online issue publication 
December 17, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 BMJ Publishing Group and British Society of Gastroenterology